Lasers as an Alternative to Formocresol and Sodium Hypochlorite Medicaments in Pulpotomy Techniques
Pulp Disease, Dental, Pulp Mummification
About this trial
This is an interventional treatment trial for Pulp Disease, Dental
Eligibility Criteria
Inclusion Criteria: Deep carious lesions present in primary molars. No history of spontaneous or persistent pain. Lack of clinical evidence of pulpal degeneration, such as pain on percussion, history of swelling or sinus tracts. Restorable teeth following completion of the procedure. Absence of radiographic signs and symptoms of pulpal degeneration. Following pulpal amputation, hemostasis could be easily achievable. Exclusion Criteria: Uncooperative children. Children with medically compromised disease. Presence of radiographical signs and symptoms of pulpal degeneration. Physiologic root resorption is more than one-third.
Sites / Locations
- Wasan Adil Fadhil
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Experimental
Experimental
Experimental
first group (Group A)
second group (Group B)
third group (Group C)
fourth group (Group D)
using a 1:5 dilution of Buckley's FC (SSA, Produits Dentaires, Switzerland). A sterile cotton pellet will be moistened with a 1:5 concentration formocresol and it will be placed on the pulp stumps for 5 minutes for achieving hemostasis before being covered with MTA. If hemostasis will not be achieved after 5 minutes, it will presume that the pulp tissue in the canal was infected, and the tooth will be removed from the research
using 3% NaOCl(Tahno-dent, Greece) A sterile cotton pellet will be moistened with a 3% NaOCl and it will be placed on the pulp chamber for 5 minutes for achieving hemostasis before being covered with MTA
In this group hemostasis will be achieved by exposure to diode laser (Biolase, epic X) of 940 nm. The laser energy will be introduced into the canal orifice through a 300 µm optical fiber at 2 W, in a contact mode with continuous mode CW(According to the user manual('EpicX_CAN_UM.pdf', no date) for 1 second at each orifice for three times to achieve complete hemostasis. During laser application patients, operator and assistant will use protective eye shields according to the safety measures of the device user manual.
Irradiation of the floor of the pulp chamber with Er,Cr:YSGG laser 2790 nm (Waterlase MD, Biolase) at a Power of 1.5 w, Frequency of 50 Hz, mode S (soft tissue mode) , 20%air and no water with a gold handpiece and Tip type MZ6, for 10 sec.(According to the manufacturer manual iPlus™ software copyright ©2016 BIOLASE, Inc.)('WaterLase-iPlus-UM.pdf', no date). In which a fixed char layer should be formed over the pulpal tissue of the canals orifices. During laser application patients, operator and assistant will use protective eye shields according to the safety measures of the device user manual.